Product Name |
D-Milnacipran D10 hydrochloride |
Alternate Names |
Milnacipran Stable Isotopes, Stable Isotopes of Milnacipran |
CAT No. |
CS-O-06780
|
CAS No. |
1217774-40-7 |
Category |
Stable Isotopes |
Stock |
IN-Stock
|
Mol. Wt. |
292.87 g/mol |
Mol. For. |
C₁₅H₁₃D₁₀ClN₂O
|
Hazardous |
This is a Hazardous Compound
|
COA |
View Sample COA
|
MSDS |
View Sample MSDS
|
Parent API |
Milnacipran |
Purity |
96.28 |
Smileys |
O=C([C@@]1(C2=CC=CC=C2)[C@@H](CN)C1)N(C([2H])([2H])C([2H])([2H])[2H])C([2H])([2H])C([2H])([2H])[2H].Cl |
Controlled |
No |
Shipping |
Free for purchase above 1000$ |
Delivery |
In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
Return |
Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
Ordering |
Place your order online or by email sales@clearsynth.com |
If you find a better price anywhere else we guarantee Price match.
D-Milnacipran D10 hydrochloride is a deuterated form of Milnacipran hydrochloride, a medication primarily used for the treatment of depression and fibromyalgia. D-Milnacipran D10 hydrochloride is a selective serotonin and norepinephrine reuptake inhibitor (SNRI) which works by increasing the levels of these neurotransmitters in the brain, thereby improving mood and reducing pain sensitivity.
Chemically, D-Milnacipran D10 hydrochloride is a derivative of Milnacipran hydrochloride, with ten deuterium atoms added to the molecular structure. Deuterium is a stable isotope of hydrogen, and its presence in the molecule can alter the pharmacokinetics and pharmacodynamics of the drug.
The recommended dosage of D-Milnacipran D10 hydrochloride varies depending on the condition being treated and the patient's individual response to the medication. It is typically taken orally, with or without food, once or twice daily.
Like all medications, D-Milnacipran D10 hydrochloride may cause side effects such as nausea, dizziness, headache, and dry mouth. It is important to inform a healthcare provider of any existing medical conditions or medications being taken before starting treatment with D-Milnacipran D10 hydrochloride.
In conclusion, D-Milnacipran D10 hydrochloride is a deuterated form of Milnacipran hydrochloride used to treat depression and fibromyalgia. Its chemical structure contains deuterium atoms which can alter the pharmacokinetics and pharmacodynamics of the drug. It is important to follow the recommended dosage and inform a healthcare provider of any existing medical conditions or medications being taken before starting treatment with D-Milnacipran D10 hydrochloride.